Wenyong Tong
Principle Scientist MSD
Seminars
Tuesday 24th February 2026
Contrasting Engineered Cell Lines vs. Cancer Cell Lines for Conventional ADC Cell-Based Potency Assay Development
2:30 pm
- Testing ADC potency through cytotoxicity assays, evaluating the tumour-killing activity of the payload following antibody internalisation
- Ensuring assay robustness and specificity through the selection of a target antigen-expressing cell line
